Nowadays, many individuals, including surprisingly almost all practising doctors, still cling on to the existing dogma that Testosterone Replacement Therapy (TRT) for more mature men what is the best testosterone booster; redirected here, not safe and contributes to an elevated incidence of prostate cancer. They do this regardless of the reality that there is not a single shred of proof to allow for this folktale and there never was.
Where did the figment of the medical imagination come from then you might well ask? Browse the medical literature as you may, I promise you that you won’t think of one peer review paper that supports the belief that boosting a man’s testosterone levels enhances his chances for developing prostate cancer or some other cancer for that matter. They simply are not there. They’re not there because the scientific proof for them is not there.
However, here’s where a lot of doctors may still be confused. If a male builds up metastatic prostate cancer one of the primary lines of therapy for him is going to be to knock out all his testosterone. Today this’s normally achieved with ease with medicines like Finasteride. As soon as this patient’s testosterone levels are lowered to near zero amounts he is going to go in no less than a short-term remission from his prostate cancer. Thus, if really low levels of testosterone are temporarily curative of prostate cancer then certainly it follows that extremely high amounts are causative. Is the fact that not just good sense?
No, sorry, that’s not just good sense which certainly is not scientific. This kind of woolly thinking – that if the absence of something is curative after that a great deal of the very same thing must be causative, is known as a corollary. Corollaries are often used in religious debate and mathematical theory. Corollaries don’t have any place in science and definitely no place in medicine. They usually leads you astray & confuse you as clearly they certainly in this particular example.
Besides, this’s equally worth noting.
Prostate cancer is predominately an ailment of older males with declining testosterone levels. It’s not at all an ailment of young men with high levels of the sex hormone circulating in their blood. Exactly how then are you able to argue that testosterone replacement therapy may be conducive to prostate cancer? Surely if anything the exact opposite would be the case although I am not attempting to make that case here.
Let us then place the final nail in the coffin of this pishogue regarding testosterone causing cancer.
A recently conducted research into the safety of testosterone replacement therapy, carried out by M.R. Feneley and M. Carruthers at The Institute of Urology and Nephrology University College, London and also you do not receive much grander than that; concluded thus:
The likelihood of prostate cancer in this particular group of men (1,500) treated with testosterone over many years was equivalent to which expected in the general population.
While I am at it then, let me just dispel an additional healthcare myth, popular among physicians about TRT. Doctors continue to cling to the fallacy which, in order to determine which men must be considered for TRT, it’s always to first of all get blood for hormonal level assay. This’s not the truth. A recently available study conducted by Trinick, Carruthers, Wheeler et al concluded as follows:
